Avastin plus chemotherapy for metastatic colorectal cancer increases over time
Results of a recent study demonstrate that the proportion of patients with metastatic colorectal cancer treated with the chemotherapy regimen FOLFOXIRI and Avastin (bevacizumab) increases over time, especially in patients younger than 50 years. . Results of this study were presented at the 2024 ASCO Gastrointestinal Cancer Symposium. FOLFOXIRI is a chemotherapy regimen consisting of […]
Individualized survival planning for colon cancer patients receiving adjuvant chemotherapy
Healthcare providers caring for colon cancer survivors need personalized survival plans for patients that monitor for cancer recurrence while also managing other long-term effects, according to a review published in It is necessary to formulate a clinical colorectal cancer.1 Although colon cancer remains one of the most commonly diagnosed cancers in the United States, the […]
PTEN-induced kinase 1 gene single nucleotide variant as a biomarker in adjuvant chemotherapy for colorectal cancer: a retrospective study | BMC Gastroenterology
tissue sample A total of 84 analytical samples were collected from surgical or biopsy specimens from 84 patients who underwent radical surgery for colorectal cancer at Saitama Medical University International Medical Center from January to December 2016. One case was excluded because the sample was too small. Therefore, we used metastatic lymph nodes instead of […]